Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG: 0874)

Guangzhou Baiyunshan Pharmaceutical Holdings Company Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 18.10B CNY in the quarter ending June 30, 2024, a decrease of -1.34%. This brings the company's revenue in the last twelve months to 76.59B, up 4.15% year-over-year. In the year 2023, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 75.52B with 6.68% growth.

• Revenue (ttm): 76.59B CNY
• Revenue Growth: +4.15%
• P/S Ratio: 0.40
• Revenue / Employee: 2.73M CNY
• Employees: 28,048
• Market Cap: 49.66B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%
Dec 31, 2020	61.67B	-3.28B	-5.05%
Dec 31, 2019	64.95B	22.72B	53.79%